Cowen & Co. analyst Phil Nadeau downgrades Graphite Bio (NASDAQ:GRPH) from Outperform to Market Perform.
Oppenheimer Maintains Outperform on Veeva Sys, Lowers Price Target to $225
Oppenheimer analyst Ken Wong maintains Veeva Sys (NYSE:VEEV) with a Outperform and lowers the price target from $250 to $225.